Name	Pyridostigmine bromide
Description	Pyridostigmine bromide (Mestinon) is a cholinesterase inhibitor with a slightly longer duration of action than NEOSTIGMINE. It is used in the treatment of myasthenia gravis and to reverse the actions of muscle relaxants.
Storage	keep away from moisture \| Powder: -20°C for 3 years \| In solvent: -80°C for 1 year \| Shipping with blue ice.
Solubility Information	H2O : 48 mg/mL (183.82 mM), Sonication is recommended. Ethanol : 49 mg/mL (187.65 mM), Sonication is recommended. DMSO : 50 mg/mL (191.48 mM), Sonication is recommended.
Keywords	Pyridostigmine bromide \| Pyridostigmine Bromide \| Pyridostigmine \| Inhibitor \| inhibit \| Cholinesterase (ChE) \| AChE
Inhibitors Related	1-Naphthyl acetate \| DL-Menthol \| Ethyl (triphenylphosphoranylidene) acetate \| 4-Methylbenzylidene camphor \| Isoeugenol acetate \| Diethyltoluamide \| sn-Glycero-3-phosphocholine \| Nizatidine \| Coumaran \| Methyl tridecanoate \| Trimethylammonium chloride \| Trimyristin
Related Compound Libraries	Failed Clinical Trials Compound Library \| Bioactive Compound Library \| Anti-Neurodegenerative Disease Compound Library \| Neuronal Signaling Compound Library \| Drug Repurposing Compound Library \| CNS-Penetrant Compound Library \| Inhibitor Library \| FDA-Approved Drug Library \| Bitter Compound library \| Immunology/Inflammation Compound Library \| Clinical Compound Library \| Bioactive Compounds Library Max

Pyridostigmine bromide NEW

Product Introduction